Disclosure of Payments to Healthcare

Collaboration between healthcare providers and the Pharmaceutical industry has for long been a positive driver for advancements in patient care and progression of innovative medicine. 

Healthcare professionals (HCPs) and healthcare organisations (HCOs) are valuable partners for Sobi. As experts in their field, they provide us with first-hand scientific and medical knowledge and unique insights into patient care. This partnership is fundamental to the progression of medical science, helping to meet various patient needs.

As part of our mission to improve life for people with rare diseases, by developing and delivering innovative therapies, we seek to bring greater transparency to an already well-regulated industry. In order to secure future collaboration, strengthen our relationships with HCPs and HCOs and to increase public awareness, Sobi is committed to meeting applicable spend transparency requirements. 

Sobi currently publishes transfer of value (in cash and kind) made to healthcare providers in 33 markets across Europe (including Russia and Ukraine) as well as the US. Disclosure in each market is described in more detail below. 

If you have any questions about the payments disclosed by Sobi please use the e-mail address [email protected]. In order for us to be able to quickly respond please state “Transparency” in the subject field.

Payments made to European healthcare

Sobi supports the European Federation of Pharmaceutical Industries and Association’s (EFPIA) Code of Practice in Europe. Since 2016 we have disclosed the transfers of value we make to HCPs and HCOs on an individual named basis as far as possible. This includes for example, sponsorship for travel and registration fees to attend medical congresses, HCP consultancy fees for speaker arrangements and grants to HCOs. Transfers of value made to HCPs and HCOs for activities related to research and development are disclosed as an aggregate number. Disclosure information is published annually (covering the previous year) on a public platform; either here at our website or in some countries, on a central platform combining data from different companies.

Sobi also adheres to local spend transparency codes and legislation in Belgium, Denmark, Estonia, France, Greece, Latvia, Lithuania, Netherlands, Portugal, Romania, Saudi Arabia, Slovakia and Turkey. 

Click on the table below to view Sobi’s disclosure reports under the EFPIA code. The methodological notes give further explanation of what we are disclosing. Links to public platforms are also accessible. 

EFPIA Disclosure reports and Methodology Notes 2024

No payments was made to following countries during 2024:

  • Lithuania
  • Malta

Payments Sobi made to Turkish HCP and HCO is not publicly disclosed according to TITCK.

Payments Sobi made to Saudi Arabia HCP and HCO is not publicly disclosed.

Austria Disclosure, 2024.pdf 106 KB
Austria Methodology Note, 2024.pdf 886 KB
Belgium Methodology Note, 2024.pdf 233 KB
Bosnia and Herzegovina Disclosure, 2024.pdf 113 KB
Bosnia and Herzegovina Methodology Note, 2024.pdf 187 KB
Bulgaria Disclosure, 2024.pdf 258 KB
Bulgaria Methodology Note, 2024.pdf 304 KB
Croatia Disclosure, 2024.pdf 172 KB
Croatia Methodology Note, 2024.pdf 346 KB
Cyprus Disclosure, 2024.pdf 220 KB
Cyprus Methodology Note, 2024.pdf 225 KB
Czech Republic Disclosure, 2024.pdf 132 KB
Czech Republic Methodology Note, 2024.pdf 346 KB
Estonia Disclosure, 2024.pdf 139 KB
Estonia Methodology Note, 2024.pdf 268 KB
Finland Disclosure, 2024.pdf 271 KB
Finland Methodology Note, 2024.pdf 273 KB
Germany Disclosure, 2024.pdf 311 KB
Germany Methodology Note 2024.pdf 928 KB
Greece Disclosure, 2024.pdf 340 KB
Greece Methodology Note, 2024.pdf 225 KB
Hungary Disclosure, 2024.pdf 136 KB
Hungary Methodology Note, 2024.pdf 345 KB
Iceland Disclosure, 2024.pdf 99.6 KB
Iceland Methodology Note, 2024.docx 52.4 KB
Italy Disclosure, 2024.pdf 481 KB
Luxembourg Disclosure, 2024.pdf 86.1 KB
Luxembourg Methodology Note, 2024.pdf 265 KB
Norway Disclosure, 2024.pdf 180 KB
Norway Methodology Note, 2024.pdf 309 KB
Poland Disclosure, 2024.pdf 296 KB
Poland Methodology Note, 2024.pdf 345 KB
Romania Disclosure, 2024.pdf 246 KB
Romania Methodology Note, 2024.pdf 345 KB
Russia Disclosure, 2024.pdf 199 KB
Russia Methodology Note, 2024.pdf 469 KB
Serbia Disclosure, 2024.pdf 85.4 KB
Serbia Methodology Note, 2024.pdf 303 KB
Slovenia Disclosure, 2024.pdf 237 KB
Slovenia Methodology Note, 2024.pdf 346 KB
Sweden Disclosure, 2024.pdf 116 KB
Sweden Methodology Note, 2024.pdf 252 KB
Switzerland Disclosure, 2024.pdf 215 KB
Switzerland Methodology Note 2024.pdf 887 KB
Ukraine Disclosure, 2024.pdf 266 KB
Ukraine Methodology Note, 2024.pdf 310 KB
Links to central platforms 2024

No payments was made to following countries during 2023:

  • Iceland
  • Lithuania
  • Malta

Payments Sobi made to Turkish HCP and HCO is not publicly disclosed according to TITCK.

Payments Sobi made to Saudi Arabia HCP and HCO is not publicly disclosed.

Austria Disclosure, 2023.pdf 100 KB
Austria Methodology Note 2023.pdf 839 KB
Bulgaria Disclosure, 2023.pdf 257 KB
Bulgaria Methodology Note, 2023.pdf 256 KB
Croatia Disclosure, 2023.pdf 156 KB
Croatia Methodology Note, 2023.pdf 256 KB
Czech Republic Disclosure, 2023.pdf 151 KB
Czech Republic Methodology Note, 2023.pdf 256 KB
Denmark-2023.pdf 35.2 KB
Estonia Disclosure, 2023.pdf 136 KB
Estonia Methodology Note, 2023.pdf 220 KB
Finland Disclosure, 2023.pdf 268 KB
Finland Methodology Note, 2023.pdf 228 KB
Germany Disclosure, 2023.pdf 379 KB
Germany Methodology Note 2023.pdf 839 KB
Hungary Disclosure, 2023.pdf 241 KB
Hungary Methodology Note, 2023.pdf 256 KB
Luxembourg Disclosure, 2023.pdf 85.9 KB
Norway Disclosure, 2023.pdf 146 KB
Norway Methodology Note, 2023.pdf 220 KB
Poland Disclosure, 2023.pdf 242 KB
Poland Methodology Note, 2023.pdf 256 KB
Romania Disclosure, 2023.pdf 235 KB
Romania Methodology Note, 2023.pdf 256 KB
Russia Disclosure, 2023.pdf 157 KB
Russia Methodology Note, 2023.pdf 380 KB
Serbia Disclosure, 2023.pdf 89.7 KB
Serbia Methodology Note, 2023.pdf 255 KB
Slovenia Disclosure, 2023.pdf 257 KB
Slovenia Methodology Note, 2023.pdf 256 KB
Switzerland Disclosure, 2023.pdf 177 KB
Switzerland Methodology Note 2023.pdf 840 KB
Ukraine Methodology Note, 2023.pdf 221 KB
Ukraine Disclosure, 2023.pdf 208 KB

No payments was made to following countries during 2022:

  • Cyprus
  • Malta
  • Lithuania
  • Luxembourg

Payments Sobi made to Turkish HCP and HCO is not publicly disclosed according to TITCK.

Payments Sobi made to Saudi Arabia HCP and HCO is not publicly disclosed.

Austria Disclosure, 2022 .pdf 137 KB
Austria Methodology Note, 2022.pdf 839 KB
Bulgaria Disclosure, 2022.pdf 242 KB
Bulgaria Methodology Note, 2022.pdf 219 KB
Croatia Disclosure, 2022.pdf 188 KB
Croatia Methodology Note, 2022.pdf 220 KB
Czech Republic Methodology Note, 2022.pdf 219 KB
Czech Republic Disclosure, 2022.pdf 150 KB
Denmark.pdf 92.5 KB
Estonia Disclosure, 2022.pdf 149 KB
Estonia Methodology Note, 2022.pdf 223 KB
Finland Disclosure, 2022.pdf 152 KB
Finland Methodology Note, 2022.pdf 241 KB
Germany Disclosure, 2022.pdf 3.32 MB
Germany Methodology Note, 2022.pdf 839 KB
Hungary Disclosure, 2022.pdf 151 KB
Hungary Methodology Note_2022.pdf 219 KB
Latvia Disclosure, 2022.pdf 212 KB
Latvia Methodology Note, 2022.pdf 223 KB
Norway Disclosure, 2022.pdf 216 KB
Norway Methodology Note, 2022.pdf 231 KB
Poland Disclosure, 2022.pdf 231 KB
Poland Methodology Note, 2022.pdf 219 KB
Romania Disclosure, 2022.pdf 215 KB
Romania Methodology Note, 2022.pdf 219 KB
Russia Dislosure, 2022.pdf 123 KB
Russia Methodology Note, 2022.pdf 284 KB
Serbia Disclosure, 2022.pdf 83.4 KB
Serbia Methodology Note, 2022.pdf 219 KB
Slovakia Disclosure, 2022 145 KB
Slovakia Methodology Note, 2022.pdf 220 KB
Slovenia Disclosure, 2022.pdf 145 KB
Slovenia Methodology Note, 2022.pdf 219 KB
Switzerland Disclosure, 2022 .pdf 183 KB
Switzerland Methodology Note, 2022.pdf 840 KB
Ukraine Disclosure, 2022.pdf 209 KB
Ukraine Methodology Note, 2022.pdf 224 KB

Payments made to Japan Healthcare

Sobi adheres to the transparency requirements from Japan Pharmaceutical Manufacturers Association (JPMA) and follows the Transparency Guideline for the Relation between Corporate Activities and Medical Institutions. 

透明性 | Sobi Japan

Payments made to Australian healthcare

Sobi adheres to the transparency requirements in Medicines Australia's Code of Conduct, which consist of a Health Consumer Organisations Report (Calendar Year), Healthcare Professionals Report (Bi-annual) and Sponsorship of Third Party Events Report (Bi-annual).

Australian disclosure report 2022

Australia TPV Report Nov2023-Apr2024

Australia HCP Report Nov2023-Apr2024

Australian disclosure report May 2024 - Oct 2024

Australia TPV Report May 2024 - Oct 2024

Australia HCP Report May 2024 - Oct 2024

Payments made to US healthcare

Sobi is committed to meeting all US state and federal reporting requirements including the Open Payments Report, commonly known as The Sunshine Act. Sobi’s disclosure of payments subject to the Sunshine Act can be found on the Centers for Medicare and Medicaid Services (CMS) open payments website.  The website provides the ability to search and view payment information on U.S. physicians and U.S. teaching hospitals as defined by CMS.

How to search payments made by the Sobi family in CMS Open Data Tool: 

  1. Open https://openpaymentsdata.cms.gov/search
  2. Select tab “Company Making Payments”
  3. Input company name:

“Swedish Orphan Biovitrum” for payments made by companies within Sobi Group excluding Sobi USA
“Sobi, Inc.” for payments made by Sobi USA
“Dova” for payments made by Dova Pharmacuticals

Global
Global
Global contacts
Europe
Austria
Belgium NL
Belgium FR
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Italy
Latvia
Lithuania
Luxembourg
Malta
Norway
Poland
Portugal
Romania
Russia
Slovakia
Slovenia
Spain
Sweden
Switzerland DE
Switzerland FR
The Netherlands
Turkey
United Kingdom
Middle East & Africa
Algeria
Bahrain
Egypt
Iraq
Jordan
Kuwait
Lebanon
Libya
Middle East
Morocco
Qatar
Oman
Saudi Arabia
Tunisia
United Arab Emirates
Asia Pacific
Australia
China
Japan
North America
USA
Canada